Phathom Pharmaceuticals Inc (PHAT)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 682k | 1.91M |
Operating Income | -45.36M | -42.53M | -46.64M | -30.08M | -31.7M | -35.66M | -69.88M | -69.95M |
Pre Tax Income | -50.92M | -51.09M | -55.05M | -37.81M | -40.97M | -43.24M | -79.57M | -82.85M |
Net Income | -50.92M | -51.09M | -55.05M | -37.81M | -40.97M | -43.24M | -79.57M | -82.85M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -45.37M | -42.54M | -46.73M | -30.06M | -31.7M | -35.83M | -69.89M | -70M |
EBITDA | -45.21M | -42.35M | -46.47M | -29.93M | -31.58M | -35.54M | -69.69M | -69.74M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 682k |
Operating Income | -1.23M | -106.22M | -125.67M | -135.08M | -172.44M | -167.31M |
Pre Tax Income | -1.29M | -255.13M | -129.07M | -143.88M | -197.72M | -201.59M |
Net Income | -1.29M | -255.13M | -129.07M | -143.88M | -197.72M | -201.59M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.213 | -10.317 | -4.526 | -4.716 | -4.768 | -3.521 |
EBIT | -1.23M | -106.23M | -125.67M | -137.14M | -172.55M | -167.5M |
EBITDA | -1.23M | -106.21M | -125.37M | -134.56M | -171.82M | -166.74M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.